OTC Medicines

This Proposed Safety Administrative Order addresses the GRASE status of codeine, codeine phosphate, and codeine sulfate as antitussive active ingredients.

Given pharmacists' drug knowledge and public accessibility, states are exploring expanding their scope of practice permanently after the pandemic emergency measures expire. Empowering pharmacists to dispense products like oral contraceptives, and other consumer healthcare products could improve access and outcomes.

This proposed Safety Administrative Order (AO) is only for the single ingredient propylhexedrine.

Providing coverage for clinically-validated, over-the-counter products capable of preventing complications or replacing higher cost prescriptions through flexible spending arrangements aligns with value-based models working to improve access and outcomes across populations.

View members-only reports outlining progress on CHPA state legislative priorities.

Having individual states impose distinct labeling rules would create confusion around critical health details printed on packaging.